IQVIA Biotech

@IQVIA_Biotech

IQVIA Biotech delivers flexible, tailored, clinical and commercial solutions designed for  and biopharma companies.

Research Triangle Park, NC
Vrijeme pridruživanja: veljača 2011.

Tweetovi

Blokirali ste korisnika/cu @IQVIA_Biotech

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IQVIA_Biotech

  1. prije 7 sati

    companies must deliver the right information at the right time. Learn how data management, warehouse, analytics and applications layers support excellence in Commercial Operations:

    Poništi
  2. prije 9 sati

    In an increasingly complex drug development environment, it is important for companies to be able to demonstrate value, even if their intention is to be acquired or to out-license their asset following proof-of-concept.

    Poništi
  3. prije 13 sati

    Innovative site communication tools can directly improve study engagement. Learn how we use various tactics to help improve study engagement and increase the success of trials in our report:

    Poništi
  4. prije 16 sati

    IO-focused biotechs can still employ traditional clinical trial parameters and processes, but considerations distinct to IO studies present unique scientific and operational challenges for even the most seasoned biotech executives.

    Poništi
  5. 4. velj

    IO-focused biotechs can still employ traditional clinical trial parameters and processes, but considerations distinct to studies present unique scientific & operational challenges for even the most seasoned biotech executives.

    Poništi
  6. 4. velj

    Webinar: How biotech companies tackled challenges to achieve launch success. Identify capabilities needed for success and how to ensure you have them.

    Poništi
  7. 4. velj

    In an increasingly complex drug development environment, it is important for companies to be able to demonstrate value, even if their intention is to be acquired or to out-license their asset following proof-of-concept.

    Poništi
  8. proslijedio/la je Tweet
    4. velj

    For the 20th anniversary of , IQVIA is sharing “20 voices for 20 years” — our unique perspective on research from our experts and personal experiences from our employees. Let's work together to help create a future without .

    Poništi
  9. proslijedio/la je Tweet
    4. velj

    On , learn more about where we are at in drug development in our Global Oncology Trends report:

    Poništi
  10. proslijedio/la je Tweet
    4. velj

    IQVIA is celebrating the 20th anniversary of by sharing “20 voices for 20 years” — our unique perspective on research from our experts and personal experiences from our employees.

    Poništi
  11. 4. velj

    Whoever you are, you can make a personal commitment to speak up for a cancer-free world. Learn more at #IAmAndIWill#WorldCancerDay

    Poništi
  12. 3. velj

    has a leadership team that inspires and dedicates decades of experience helping our customers deliver innovative solutions to those who need them most. Meet the team here:

    Poništi
  13. 3. velj

    companies must deliver the right information at the right time. Learn how data management, warehouse, analytics and applications layers support excellence in Commercial Operations:

    Poništi
  14. 3. velj

    You want to get the right treatments to the right patients. IQVIA Biotech wants to help you pave a more predictable path to get there.

    Poništi
  15. 3. velj

    Innovative site communication tools can directly improve study engagement. Learn how we use various tactics to help improve study engagement and increase the success of trials in our report:

    Poništi
  16. 31. sij

    IO-focused biotechs can still employ traditional clinical trial parameters and processes, but considerations distinct to studies present unique scientific & operational challenges for even the most seasoned biotech executives.

    Poništi
  17. 31. sij

    Are you trying to figure out how you can go to market on your own, while keeping fixed costs stable? IQVIA Biotech can help. Start the discussion:

    Poništi
  18. 31. sij

    An eNPV provides stakeholders with a robust, neutral view on your drug development. It can be used to compare pathways, molecules or indications, and show the impact of trade-offs. Learn more here:

    Poništi
  19. 28. sij

    Despite progress in the approval of new , their coming of age poses three major challenges. We discuss budget impact, growing competition and diverse players in our white paper here:

    Poništi
  20. 28. sij

    You want to get the right treatments to the right patients. IQVIA Biotech wants to help you pave a more predictable path to get there.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·